A peer-level look at how family physicians and general practitioners prioritize hypertension, weight, glycemia, lipids, adherence, and long-term prevention when several cardiometabolic risks arrive in the same consultation.
Audience: Family Physicians / General Practitioners
Countries: 6
Completion Rate: 79.5%
SGID: 9004548
-Hero findings
– Quick Read — Key Findings
Family physicians and GPs often see risk factors together: blood pressure, weight, glycemia, lipids, kidney function, family history, lifestyle, and treatment feasibility compete for attention in a short consultation.
The survey reflects that reality: hypertension is the most selected trigger for intervention at 47.0%, yet obesity or excess weight follows at 31.7%. The question is not simply whether a patient has one abnormal value, but which risk is most actionable now, which will change the trajectory if treated early, and what can be sustained outside the consultation. That fits contemporary guidance: the 2025 AHA/ACC high-blood-pressure guideline frames elevated blood pressure as a major modifiable risk tied to overall cardiovascular risk, and the 2024 ESC hypertension guideline emphasizes risk across a continuum rather than a simple normal-versus-hypertensive divide.
47.0% select hypertension as the cardiometabolic risk most likely to trigger intervention; 31.7% select obesity or excess weight.
That hypertension leads at 47.0% with obesity close behind at 31.7% suggests FP/GPs respond strongly to an immediately measurable risk while treating excess weight as more than a background issue; WHO now frames obesity as a chronic disease linked to type 2 diabetes, cardiovascular, liver and kidney disease. The tension is timing: hypertension creates a clear treatment threshold, while excess weight needs a longer conversation about complications, readiness, options, access and sustained follow-up, and both can signal risk before symptomatic disease appears.
HbA1c and glycemic status lead at 36.1%, but blood-pressure profile follows closely at 31.0%; LDL-C/lipid profile accounts for 20.2% and BMI/waist circumference 12.6%.
No assessment dominates: HbA1c leads at 36.1%, with blood pressure (31.0%) and LDL-C (20.2%) close behind, so the intervention threshold is spread across metabolic and cardiovascular signals. For a primary-care clinician, the next action depends less on one abnormal measurement than on how several alter total risk, which fits NICE guidance on systematic cardiovascular-risk identification and diabetes guidance on managing modifiable risk in prediabetes, a direction toward integrated assessment rather than isolated target chasing.
49.0% prioritize intensive lifestyle intervention first. When lifestyle intervention is insufficient, 43.4% select antihypertensive therapy and 35.6% weight-management pharmacotherapy.
The sequence suggests a practical two-stage model: start with broad risk reduction, then target the dominant residual risk. Current blood-pressure guidance recommends lifestyle measures for all adults with elevated blood pressure or hypertension while defining when to add medication, and obesity guidance frames weight management as long-term, multimodal care rather than advice alone. Only 1.6% select immediate specialist referral when lifestyle is insufficient, which does not make referral unimportant but reinforces how much prevention and early escalation stay within the primary-care workflow.
43.6% say multiple cardiovascular risk factors change management the most, ahead of hypertension with CKD at 27.5%.
That multiple cardiovascular risk factors (43.6%) change management more than any single named subgroup is one of the clearest signals that primary-care risk is cumulative: several moderate abnormalities may need a different strategy from one isolated factor, and kidney disease shifts the picture further, especially alongside hypertension. The open cases reinforce it, describing combinations of obesity, hypertension, dyslipidemia, diabetes or prediabetes, kidney risk and behavioral factors; the challenge is not seeing that each matters but choosing a sequence the patient can sustain.
62.6% identify patient adherence as what most limits early intervention. In a separate question, 40.4% again select patient adherence as the biggest operational barrier to preventive care.
Patient adherence dominates at 62.6%, the strongest repeated theme in the dataset, shifting the focus from whether clinicians know what to do toward whether the plan survives real life; open responses cite medication cost, insurance coverage, persistence with weight loss and lapses in prescribed therapy. Adherence is not a single patient trait, it reflects treatment burden, side effects, affordability, beliefs, competing priorities, communication and follow-up, so identifying the specific barrier may matter as much as choosing the intervention.
The findings point to a recognizable primary-care pattern: hypertension most often triggers action, glycemic status most often sets the threshold, lifestyle is the preferred first move, and clustered cardiovascular risk changes management more than any single subgroup. Yet the strongest barrier is not a missing clinical option, it is adherence.
Cardiometabolic prevention succeeds when clinicians identify risk early, choose the dominant target, escalate when lifestyle is insufficient, and keep the plan workable over time. That sustained blood-pressure control and weight reduction lead the long-term outcome question shows success is broader than one laboratory result.
The future choices are telling: personalized prevention algorithms and integrated primary-care pathways are almost tied. FP/GPs may need not more isolated data points but better ways to turn existing data into coordinated, sustainable action.
You have read the summary
Discover the complete research behind these insights, or become part of future studies with MDForLives.
Direct answers to common professional questions about risk assessment, early intervention, hypertension, weight management, adherence, and referral.
Direct answers to the questions healthcare professionals are most likely to ask about these findings.
